News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Kristen Philipkoski, Wired News | 11.10.2004
Stem-cell researchers have little time to celebrate the $3 billion that California voters lavished on them Nov. 2. There's a...
By Paul Elias, Associated Press | 11.09.2004
A 21st-century gold rush is on in California after the voters approved $3 billion for human embryonic stem cell research....
By Kristen Philipkoski, Wired News | 11.08.2004
California may now be a haven for stem-cell research, but the federal government is still debating the legality of some...
By Steve Usdin, The Bernstein Report on Biobusiness | 11.08.2004

Passage of Proposition 71, the $3 billion California Stem Cell Research and Cures Initiative, was a sure thing: Offered up...

By Denise Gellene, Los Angeles Times | 11.07.2004
Will last week's $3-billion California stem cell initiative one day grow new business?

The massive bond measure known as Proposition...
By Mike Schwartz, The Press Enterprise | 11.06.2004
Some say elite of stem-cell world can be lured to area
Fueled by visions of Prop. 71 dollars and high-tech...
By Nicholas Wade, New York Times | 11.04.2004
A male achievement that is perhaps insufficiently celebrated is that with every heartbeat a man generates 1,000 sperm, each of...
By Tim Simmers, Oakland Tribune | 11.04.2004
Foes who support research worry about industry 'giveaway'


Biotechnology leaders and academics embraced Tuesday's passage of the
$3 billion bond...